The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Longitudinal analysis of health care costs in patients with childhood onset inherited retinal dystrophies compared to healthy controls
Open accessAbstract
Background: We evaluated health care costs in patients with childhood onset visual impairment caused by inherited retinal dystrophies (IRD). Methods: The IRD cohort, identified from the Danish Registry of Blind and Partially Sighted Children, was compared to age- and sex-matched controls from the national, Danish population registry. Information on health care expenditures for somatic and psychiatric in- and outpatient services, purchase of prescription medications and paid assistance at home were obtained from national registries for the years 2002–2017. Results: We included 412 in the IRD cohort (6,290 person years) and 1656 (25,088 person years) in the control cohort. Average, annual health care expenditures from age 0–48 years of age were €1,488 (SD 4,711) in the IRD cohort and €1,030 (4,639) in the control cohort. The largest difference was for out-patient eye care (13.26 times greater, 95% confidence interval 12.90–13.64). Psychiatric in-patient expenditures were 1.71 times greater (95% CI 1.66–1.76) in the IRD cohort but psychiatric out-patient health care costs were comparable between groups. Conclusions: Health care costs were approximately 40% greater in the IRD cohort compared to an age- and sex-matched sample from the general Danish population. This is relevant in the current situation with a number of trials aimed at treating IRDs using genetically based therapies. Although eye care expenditures were many times greater, they made up < 10% of the total health care expenditures even in the IRD cohort. The reduced costs related to injuries in the visually impaired cohort was a surprising finding but may reflect a reduced propensity to seek medical care rather than a reduced risk of injuries.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Of note, eight studies [47–53, 59] did not distinguish between costs of different conditions, further hindering the interpretation.”
From The economic impact of retinal diseases for which gene therapy is emerging: a systematic literature review (2025) · cites this paper as [59]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The direct medical costs accounted for both ophthalmological and non-ophthalmological care and were estimated, on average, at $674 per patient per year, across all age groups combined.”
From The economic impact of retinal diseases for which gene therapy is emerging: a systematic literature review (2025) · cites this paper as [59]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As for direct non-medical costs, they pertained to formal care and were estimated at $241 per patient per year.”
From The economic impact of retinal diseases for which gene therapy is emerging: a systematic literature review (2025) · cites this paper as [59]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“while this review identified only one original study estimating costs of IRDs in Europe [59] (reporting direct costs of $900 per patient per annum)”
From The economic impact of retinal diseases for which gene therapy is emerging: a systematic literature review (2025) · cites this paper as [59]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“A Danish study was the only study in this review to describe costs associated with IRDs [59].”
From The economic impact of retinal diseases for which gene therapy is emerging: a systematic literature review (2025) · cites this paper as [59]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Russell, S., Bennett, J., Wellman, J. A., Chung, D. C., Yu, Z.-F., Tillman, A., Wittes, J., Pappas, J., Elci, O., McCague, S., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31868-8 · Cited by 1,952
Too much ado about two-part models and transformation?
Buntin, M. B., & Zaslavsky, A. M. (2004) · Journal of Health Economics · doi:10.1016/j.jhealeco.2003.10.005 · Cited by 732
Epidemiology of blindness in children
Solebo, A. L., Teoh, L., & Rahi, J. (2017) · Archives of Disease in Childhood · doi:10.1136/archdischild-2016-310532 · Cited by 383
Kumaran, N., Moore, A. T., Weleber, R. G., & Michaelides, M. (2017) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2016-309975 · Cited by 334
Are There “Autistic‐like” Features in Congenitally Blind Children?
Brown, R., Hobson, R. P., Lee, A., & Stevenson, J. (1997) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.1997.tb01696.x · Cited by 257 · cited 1×
“autistic features have been described among congenitally blind children [9] and mental and behavioral disorders are common in children with Usher syndrome.”
BackgroundAre we blind to injuries in the visually impaired? A review of the literature
Legood, R., Scuffham, P., & Cryer, C. (2002) · Injury Prevention · doi:10.1136/ip.8.2.155 · Cited by 209
Central and Peripheral Visual Impairment and the Risk of Falls and Falls with Injury
Patino, C. M., McKean-Cowdin, R., Azen, S. P., Allison, J. C., Choudhury, F., & Varma, R. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2009.06.063 · Cited by 182
Galvin, O., Chi, G., Brady, L., Hippert, C., Del Valle Rubido, M., Daly, A., & Michaelides, M. (2020) · Clinical Ophthalmology · doi:10.2147/opth.s241928 · Cited by 116
Health-related quality of life in survivors of childhood cancer: the role of chronic health problems
Rueegg, C. S., Gianinazzi, M. E., Rischewski, J. R., Popovic, M. B., von der Weid, N., Michel, G., & Kuehni, C. E. (2013) · Journal of Cancer Survivorship · doi:10.1007/s11764-013-0288-4 · Cited by 94
Johnson, S. J., Buessing, M. G., O’Connell, T., Pitluck, S., & Ciulla, T. A. (2019) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2019.2512 · Cited by 83
Cited by
Cost-of-illness studies of inherited retinal diseases: a systematic review
Ng, Q. X., Ong, C., Yaow, C. Y. L., Chan, H. W., Thumboo, J., Wang, Y., & Koh, G. C. H. (2024) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-024-03099-9 · Cited by 27
Chay, J., Tang, R. W. C., Tan, T.-E., Chan, C. M., Mathur, R., Lee, B. J. H., Chan, H. H., Sim, S. S. K. P., Farooqui, S., Teo, K. Y. C., et al. (2023) · Eye · doi:10.1038/s41433-023-02624-7 · Cited by 15
Willmington, C., Kirby, A., & Murphy, A. (2025) · Health Economics Review · doi:10.1186/s13561-025-00707-7
“This observational study with an implied healthcare payer perspective, reported direct medical costs by age group at the patient level [59] (see Fig.”
Influential
Metadata
- Authors
- Kessel, L., Kjellberg, J., Ibsen, R., Rasmussen, A., Nissen, K. R., & la Cour, M.
- Affiliations
- University of Copenhagen (DK)
- VIVE - The Danish Center for Social Science Research (DK)
- Glostrup Hospital (DK)
- Corresponding author
- Kessel, Line
- Venue
- BMC Ophthalmology
- Published
- 2022-12-02
- Volume
- 22
- Issue
- 1
- Pages
- 466-466
- ISSN
- 1471-2415 (ISSN-L)
- PMC
- PMC9716977
- OpenAlex
- W4311106753
- Cited by
- 8
- References
- 21
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 3 · 2023: 1
- FWCI
- 0.57
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- BMC Ophthalmology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Øjenforeningen [Fight for Sight, Denmark]
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Keywords
- inherited retinal disease, health care costs, health care expenditure, eye care, psychiatric hospitalization, prescription drugs, home care support, injury risk, gene therapy
- MeSH terms
- Adolescent, Adult, Ambulatory Care, Child, Child, Preschool, Health Expenditures, Humans, Infant, Infant, Newborn, Middle Aged, Health Care Costs, Persons with Visual Disabilities, Young Adult, Retinal Dystrophies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Longitudinal analysis of health care costs in patients with childhood onset inherited retinal dystrophies compared to healthy controls. https://app.cochat.ai/papers/10.1186/s12886-022-02708-0
- The paper
- Kessel, L., Kjellberg, J., Ibsen, R., Rasmussen, A., Nissen, K. R., & la Cour, M. (2022). Longitudinal analysis of health care costs in patients with childhood onset inherited retinal dystrophies compared to healthy controls. BMC Ophthalmology. https://doi.org/10.1186/s12886-022-02708-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
